For the second consecutive year we are the Best Urology in Italy (and 24th in the World - 27th in 2023) according to the Ranking of World’s Best Specialized Hospitals 2024 by Newsweek.
Special thanks to all the Members of my fantastic Team!!!!!!
https://t.co/BJJ8zQeXOi
❓How to select candidates for renal biopsy. Great work led by @albertoma90
➡️Age and RM size as key interacting factors
Have a look at the article here: https://t.co/LkQJgS91Ni
🚨 Which surgeries have been privileged during #COVID19 pandemic in the 3 largest county hospitals in #Lombardy?
🎯 Pandemic recommendations provided by experts should be tailored according to hospital capacity and different levels of the pandemic
👉 https://t.co/JtxwETYYRU
🤔 Want to predict continence status after RARP?
🔥 Check out our novel nomogram for the prediction of postoperative ICIQ score
💻 Prospectively collected data from the Belgian Cancer Registry
🇧🇪 9000+ patients treated in 25 centers
➡️ https://t.co/bkZgs2tYIs
Check out our article on changes in urological activity during #COVID19 outbreak in #Bergamo@hpg23bg published in @EurUrolFocus
https://t.co/Ra7ne58CBW
@effedimarzo@RNaspro Already 2 mos postponed surgery for a 6cm kidney tumor due to pulmonary embolism, now in NOACs. Dedicated OR for COVID patients. Low pneumoperitoneum pressure. Evacuation of gas only through <0.01 µm filter connected to standard trocars.
The @ERUSrobotics Curriculum for RAPN: structured training for #kidney#cancer robotic surgery works without harm for the patients. For the first time ever, comprehensive study moving from structure definition to training and clinical data at @EUplatinum https://t.co/g56PzK5DOk.
Lymph node invasion is the most informative predictor of early disease progression in #kidneycancer .
Important diagnostic role of LND.
@Paolo_Capog@AndreaNecchi
https://t.co/jdLj4arrnx
In this study we demonstrated that progression to #metastasis within 5 yrs of RP represents the most informative intermediate clinical endpoint for predicting OS in HR #prostatecancer#patients@GGandaglia @ABrigantiMD @EurUrolOncol EMPaCT investigators
https://t.co/IFtgU6BY64